St. Thomas Law Review
October 19, 2026By Peterson Lera
Social media wellness influencers have drawn growing attention for promoting injectable peptides as a route to better health. The promised benefits range from improved sleep and weight loss to muscle growth. Peptides are short chains of amino acids that act as chemical messengers in the body, helping control things like hormones, digestion, inflammation, and the […]
Administrative LawFDAFeaturedPharmaceuticalsPublic Health
October 24, 2025By Ciara Maytan
Ozempic is no longer just a prescription—it has become a cultural phenomenon. From Hollywood red carpets to TikTok feeds, Glucagon-Like Peptide-1 (“GLP-1”) drugs like Ozempic, Wegovy, and Mounjaro are hailed as “miracle” fixes for weight loss. Yet, behind the hype lies an uncomfortable truth: These drugs surged into widespread use quickly, and patients are now […]
Contract LawFeaturedHealth CarePharmaceuticals
October 21, 2024By Chelsea Barcenas
On September 9, 2024, the U.S. House of Representatives voted 306-81 in favor of H.R. 8333, known as the Biosecure Act.[i] The Biosecure Act prohibits U.S. companies from entering into contracts with biotechnology “companies of concern” and their U.S. subsidiaries.[ii] Specifically, the bill blocks partnerships with BGI Group, MGI, WuXi AppTec, WuXi Biologics, and […]
